The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of White Marvin L since 2015.
This trader's CIK number is 1493324.
At the time of last reporting, White Marvin L was the President and CEO of Aptevo Therapeutics Inc.. (stock ticker symbol APVO).
Also see all insider trading activities at Aptevo Therapeutics Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2015 | WPG | 5,000 | $71,150 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | APVO | 0 | $0 | 0 | $0 | 24 | $0 |
| 2024 | APVO | 0 | $0 | 0 | $0 | 4,792 | $0 |
| 2023 | APVO | 0 | $0 | 0 | $0 | 4,791 | $0 |
| 2022 | APVO | 0 | $0 | 0 | $0 | 4,792 | $0 |
| 2019 | APVO | 90,000 | $76,100 | 0 | $0 | 0 | $0 |
| 2018 | APVO | 10,000 | $23,800 | 100,000 | $293,000 | 35,644 | $0 |
| 2017 | APVO | 0 | $0 | 0 | $0 | 53,471 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2016 | EBS | 0 | $0 | 33,134 | $1,173,606 | 33,134 | $577,326 |
1. Washington Prime Group Inc. (WPG)
2. Aptevo Therapeutics Inc. (APVO)
3. Emergent Biosolutions Inc. (EBS)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2015-06-19 | WPG | Buy | 1,500 | 14.30 | 21,450 |
| 2015-06-22 | WPG | Buy | 3,500 | 14.20 | 49,700 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-17 | APVO | Option Ex | 10 | .00 | 0 |
| 2025-03-02 | APVO | Option Ex | 8 | .00 | 0 |
| 2025-03-03 | APVO | Option Ex | 6 | .00 | 0 |
| 2024-01-28 | APVO | Option Ex | 4,792 | .00 | 0 |
| 2023-01-29 | APVO | Option Ex | 4,791 | .00 | 0 |
| 2022-01-29 | APVO | Option Ex | 4,792 | .00 | 0 |
| 2019-06-14 | APVO | Buy | 50,000 | .88 | 44,000 |
| 2019-05-20 | APVO | Buy | 30,000 | .81 | 24,300 |
| 2019-05-14 | APVO | Buy | 10,000 | .78 | 7,800 |
| 2018-12-04 | APVO | Buy | 10,000 | 2.38 | 23,800 |
| 2018-05-21 | APVO | Option Ex | 35,644 | .00 | 0 |
| 2018-03-19 | APVO | Sale | 100,000 | 2.93 | 293,000 |
| 2017-05-22 | APVO | Option Ex | 53,471 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2016-03-07 | EBS | Option Ex | 33,134 | 17.42 | 577,326 |
| 2016-03-07 | EBS | Sale | 33,134 | 35.42 | 1,173,606 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by White Marvin L (President and CEO of Aptevo Therapeutics Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.